U.S. Medical Device Testing Services Market to Reach USD 7.05 Billion by 2035 at a 10.16% CAGR, While Europe Benefits from ...

Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced successful results ...

Polyrizon Ltd. (NASDAQ: PLRZ) shares gathered steam to begin Thursday trading. The development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced ...

Medical innovation is exciting. It’s thrilling to think a new therapy, device or product can improve the quality of or save ...

In a constantly growing global medical device market, marked by increasingly strict regulation and rising demands in patient ...

OMNIVISION, a leading global developer of semiconductor solutions, including advanced digital imaging, analog, and display technology, today announced the availability of several new OVMed ® ...

As combination products continue to advance healthcare, ensuring compatibility between drug formulations and device components is essential for safety and performance. This webinar provides a focused ...

(a) Structural decomposition diagrams of the soft sheet robot and magnetorheological fluids. (b) Diagram of the 3D model of the soft sheet robot. (c) Microstructure diagram of magnetorheological ...

Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development-stage biotech company specializing in the development of innovative intranasal ...

Researchers at Central South University and MedArt developed a biodegradable cranial fixation device that strengthens bone healing, reduces complications, and offers a safer alternative to traditional ...

“I was walking with fear in every step, terrified I might fall at any moment,” says Anima Guria, a Parkinson’s patient (as told by her son, Ankit Guria). “My maternal grandfather was diagnosed with ...